New York State Common Retirement Fund
SLDB icon

New York State Common Retirement Fund’s Solid Biosciences SLDB Stock Holding History

New York State Common Retirement Fund’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$170K Buy
17,000
+9,900
+139% +$75.1K ﹤0.01% 2435
2026
Q1 		$51.1K Hold
7,100
– – ﹤0.01% 2812
2025
Q4 		$40K Hold
7,100
– – ﹤0.01% 2966
2025
Q3 		$43.8K Hold
7,100
– – ﹤0.01% 2985
2025
Q2 		$34.6K Hold
7,100
– – ﹤0.01% 3036
2025
Q1 		$26.3K Hold
7,100
– – ﹤0.01% 2936
2024
Q4 		$28.4K Hold
7,100
– – ﹤0.01% 2989
2024
Q3 		$49.5K Sell
7,100
-10,400
-59% -$84.3K ﹤0.01% 2868
2024
Q2 		$99.2K Buy
+17,500
New +$157K ﹤0.01% 2859
2022
Q3 		– Sell
-33
Closed – – 3427
2022
Q2 		$0 Sell
33
-1,466
-98% -$15.2K ﹤0.01% 3532
2022
Q1 		$27K Hold
1,499
– – ﹤0.01% 3264
2021
Q4 		$39K Sell
1,499
-8
-0.5% -$245 ﹤0.01% 3261
2021
Q3 		$54K Sell
1,507
-1,908
-56% -$81K ﹤0.01% 3234
2021
Q2 		$187K Buy
3,415
+2,362
+224% +$156K ﹤0.01% 3068
2021
Q1 		$87K Hold
1,053
– – ﹤0.01% 3107
2020
Q4 		$120K Hold
1,053
– – ﹤0.01% 2950
2020
Q3 		$32K Hold
1,053
– – ﹤0.01% 3189
2020
Q2 		$46K Hold
1,053
– – ﹤0.01% 3160
2020
Q1 		$38K Hold
1,053
– – ﹤0.01% 3038
2019
Q4 		$70K Hold
1,053
– – ﹤0.01% 3078
2019
Q3 		$163K Buy
1,053
+746
+243% +$84.4K ﹤0.01% 2861
2019
Q2 		$26K Hold
307
– – ﹤0.01% 3216
2019
Q1 		$42K Sell
307
-593
-66% -$149K ﹤0.01% 3086
2018
Q4 		$362K Buy
900
+200
+29% +$94K ﹤0.01% 2428
2018
Q3 		$495K Hold
700
– – ﹤0.01% 2414
2018
Q2 		$374K Hold
700
– – ﹤0.01% 2586
2018
Q1 		$79K Buy
+700
New +$236K ﹤0.01% 2983

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

New York State Common Retirement Fund's SLDB Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Solid Biosciences (SLDB) stake by 139% in Q2 2026, buying an estimated $75.1K and bringing the position to 17,000 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #2435.

New York State Common Retirement Fund first reported a position in SLDB in Q1 2018 and has held it in 27 quarters since. The position peaked at $495K in Q3 2018. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • New York State Common Retirement Fund held 17,000 shares of Solid Biosciences worth $170K as of Q2 2026.
  • New York State Common Retirement Fund bought 9,900 Solid Biosciences shares in Q2 2026, an estimated $75.1K.
  • Solid Biosciences made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2435 holding.
  • New York State Common Retirement Fund first reported a position in Solid Biosciences in Q1 2018 and has held it in 27 quarters since.
  • New York State Common Retirement Fund's Solid Biosciences position peaked at $495K in Q3 2018.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.